A similar scenario has been described for patients with paraneoplasic scleroderma, in whom genetic alterations of the POLR3A locus and resulting T and B cell responses against the POLR3A gene product were detected in 75% of tumors but were absent from control tumors (163). Here, POLR3A is linked to scleroderma.